Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial
Frans L. Moll(Metallco (Norway)), Marco J.D. Tangelder(UniQure (Netherlands)), Michael R. Jaff(Boston Scientific (United States)), Thomas Zeller(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Michele F. Mercur(Daiichi Sankyo (United States)), Gary M. Ansel(Clinical Insights), Iris Baumgärtner(Hirslanden Klinik Beau-Site), George L. Adams(Rex Hospital), John H. Rundback(Holy Name Medical Center), Michael Grosso(Daiichi Sankyo (United States)), Erich Minar(Medical University of Vienna), Min Lin(Zhejiang Chinese Medical University), Chuke Nwachuku(National Heart Lung and Blood Institute)
Cited by 97
Related Papers
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2004|2.9k
American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
|Blood Advances|2020|1.4k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
Editor's Choice – Management of Descending Thoracic Aorta Diseases
|European Journal of Vascular and Endovascular Surgery|2017|1.2k
Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery
|New England Journal of Medicine|2006|1.2k